Recombinant Vesicular Stomatitis Virus Transduction of Dendritic Cells Enhances Their Ability to Prime Innate and Adaptive Antitumor Immunity
Open Access
- 1 August 2009
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 17 (8) , 1465-1472
- https://doi.org/10.1038/mt.2009.95
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Culture of myeloid dendritic cells from bone marrow precursorsJournal of Visualized Experiments, 2008
- Engineered lentivector targeting of dendritic cells for in vivo immunizationNature Biotechnology, 2008
- DC-based cancer vaccinesJournal of Clinical Investigation, 2007
- Dendritic Cells Prime Natural Killer Cells by trans-Presenting Interleukin 15Immunity, 2007
- Vaccinia virus infection induces dendritic cell maturation but inhibits antigen presentation by MHC class IICellular Immunology, 2007
- Dendritic Cell‐Based Immunotherapy of Malignant Melanoma: Success and LimitationsJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2007
- Matrix Protein Mutant of Vesicular Stomatitis Virus Stimulates Maturation of Myeloid Dendritic CellsJournal of Virology, 2006
- Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccinationExperimental & Molecular Medicine, 2004
- Vesicular stomatitis virus: re-inventing the bulletTrends in Molecular Medicine, 2004
- MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cellsCancer Gene Therapy, 2002